Canada’s Valeant Pharmaceuticals International Inc. (NYSE:VRX) said it offered to buy Botox maker Allergan Inc to boost its skin and eye-care portfolio. Valeant said it had offered to pay $48.30 per share in cash and 0.83 of its common share for each Allergan share. Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) shares after opening at $122.10 moved to $126.12 on last trade day and at the end of the day closed at $126.01. Company price to sales ratio in past twelve months was calculated as 7.29 and price to cash ratio as 70.04. Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) showed a positive weekly performance of 6.08%.
Novartis AG (ADR) (NYSE:NVS) on Tuesday announced that it will acquire GlaxoSmithKline’s NYSE:GSK cancer-drug business for $14.5 billion and would sell most of its vaccine business to GSK for $7.1 billion plus royalties. Novartis AG (ADR) (NYSE:NVS) shares advanced 0.93% in last trading session and ended the day on $85.46. NVS return on equity ratio is recorded as 13.00% and its return on assets is 7.40%. Novartis AG (ADR) (NYSE:NVS) yearly performance is 21.95%.
GlaxoSmithKline plc (ADR) (NYSE:GSK) today said the multi-billion dollar global deal between parent GlaxoSmithKline Plc and Swiss drug major Novartis won’t affect its business in India. GlaxoSmithKline plc (ADR) (NYSE:GSK) shares moved up 1.16% in last trading session and was closed at $53.12, while trading in range of $52.58 – $53.18. GlaxoSmithKline plc (ADR) (NYSE:GSK) year to date (YTD) performance is 0.84%.
AstraZeneca PLC (NYSE:AZN) was a big mover last session with shares rising nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
AstraZeneca plc (ADR) (NYSE:AZN) weekly performance is 10.38%. On last trading day company shares ended up $69.10. AstraZeneca plc (ADR) (NYSE:AZN) distance from 50-day simple moving average (SMA50) is 5.92%. Analysts mean target price for the company is $67.55.
Leave a Reply